Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
PaperCitations, authors & open-access status
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 93 citations, 2019 year and closed oa status.
93
Citations
2019
Year
closed
OA Status